Plasma membrane localization and fusion inhibitory activity of the cowpox virus serpin SPI-3 require a functional signal sequence and the virus encoded hemagglutinin

Virology

Volumn 306, Issue 2, 2003, Pages 289-302

  Brum, Lauren M ^a   Turner, Peter C ^a   Devick, Heather ^a   Baquero, M Teresa ^a   Moyer, Richard W ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

EEV; Fusion; HA; Localization; Poxvirus; Serpin; SPI 3

Indexed keywords

SERINE PROTEINASE INHIBITOR; SERPIN SPI 3; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL FUSION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; COWPOX VIRUS; GENE DELETION; GLYCOSYLATION; GOLGI COMPLEX; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VIRUS INFECTION;

COWPOX VIRUS; POXVIRIDAE; STAPHYLOCOCCUS PHAGE 3A;

EID: 0037440764     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00017-X     Document Type: Article

References (45)

1. Brooks M.A., Ali A.N., Turner P.C., Moyer R.W. A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells. J. Virol. 12:1995;7688-7698.
2. Cameron C., Hota-Mitchell S., Chen L., Barrett J., Cao J.X., Macaulay C., Willer D., Evans D., McFadden G. The complete DNA sequence of myxoma virus. Virology. 264:1999;298-318.
3. Dahlen J.R., Foster D.C., Kisiel W. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues. Biochemical And Biophysical Research Communications. 244:1998;172-177.
4. Dennis J.W., Granovsky M., Warren C.E. Protein glycosylation in development and disease. Bioessays. 21:1999;412-421.
5. Djie M.Z., Stone S.R., Le Bonniec B.F. Intrinsic specificity of the reactive site loop of alpha1-antitrypsin, alpha1-antichymotrypsin, antithrombin III, and protease nexin I. J. Biol. Chem. 272:1997;16268-16273.
6. Falkner F.G., Moss B. Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64:1990;3108-3111.
7. Fuerst T.R., Niles E.G., Studier F.W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
8. Gagliardini V., Fernandez P.A., Lee R.K., Drexler H.C., Rotello R.J., Fishman M.C., Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science. 263:1994;826-828.
9. Griffiths G., Roos N., Schleich S., Locker J.K. Structure and assembly of intracellular mature vaccinia virus thin- section analyses . J. Virol. 75:2001;11056-11070.
10. Griffiths G., Wepf R., Wendt T., Locker J.K., Cyrklaff M., Roos N. Structure and assembly of intracellular mature vaccinia virus isolated-particle analysis . J. Virol. 75:2001;11034-11055.
11. Grigoryev S.A., Bednar J., Woodcock C.L. MENT, a heterochromatin protein that mediates higher order chromatin folding, is a new serpin family member. J. Biol. Chem. 274:1999;5626-5636.
12. Hollinshead M., Vanderplasschen A., Smith G.L., Vaux D.J. Vaccinia virus intracellular mature virions contain only one lipid membrane. J. Virol. 73:1999;1503-1517.
13. Isaacs S.N., Kotwal G.J., Moss B. Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses. Virology. 178:1990;626-630.
14. Kerr S.M., Smith G.L. Vaccinia virus DNA ligase is nonessential for virus replication recovery of plasmids from virus-infected cells . Virology. 180:1991;625-632.
15. Komiyama T., Ray C.A., Pickup D.J., Howard A.D., Thornberry N.A., Peterson E.P., Salvesen G. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J. Biol. Chem. 269:1994;19331-19337.
16. Law K.M., Smith G.L. A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. J. Gen. Virol. 73:1992;549-557.
17. Lis H., Sharon N. Protein glycosylation. Structural and functional aspects. Eur. J. Biochem. 218:1993;1-27.
18. Locker J.K., Kuehn A., Schleich S., Rutter G., Hohenberg H., Wepf R., Griffiths G. Entry of the two infectious forms of vaccinia virus at the plasma membrane is signaling-dependent for the IMV but not the EEV. Molecular Biology of the Cell. 11:2000;2497-2511.
19. Lomas D.A., Evans D.L., Upton C., McFadden G., Carrell R.W. Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J. Biol. Chem. 268:1993;516-521.
20. Maass N., Hojo T., Zhang M., Sager R., Jonat W., Nagasaki K. Maspin-A novel protease inhibitor with tumor-suppressing activity in breast cancer. Acta Oncologica. 39:2000;931-934.
21. Macen J.L., Upton C., Nation N., McFadden G. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology. 195:1993;348-363.
22. Martinez Pomares L., Stern R.J., Moyer R.W. The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of extracellular enveloped virus, and is secreted into the medium. J. Virol. 67:1993;5450-5462.
23. Mathew E., Sanderson C.M., Hollinshead M., Smith G.L. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J. Virol. 72:1998;2429-2438.
24. Moon K.B., Turner P.C., Moyer R.W. SPI-1-dependent host range of rabbitpox virus and complex formation with cathepsin G is associated with serpin motifs. J. Virol. 73:1999;8999-9010.
25. Nielsen H., Engelbrecht J., Brunak S., von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 10:1997;1-6.
26. Palumbo G.J., Pickup D.J., Fredrickson T.N., McIntyre L.J., Buller R.M. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology. 172:1989;262-273.
27. Payne L.G., Norrby E. Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. J. Gen. Virol. 32:1976;63-72.
28. Pemberton P.A., Tipton A.R., Pavloff N., Smith J., Erickson J.R., Mouchabeck Z.M., Kiefer M.C. Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface. J. Histochem. Cytochem. 45:1997;1697-1706.
29. Quan L.T., Caputo A., Bleackley R.C., Pickup D.J., Salvesen G.S. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 270:1995;10377-10379.
30. Ray C.A., Black R.A., Kronheim S.R., Greenstreet T.A., Sleath P.R., Salvesen G.S., Pickup D.J. Viral inhibition of inflammation cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme . Cell. 69:1992;597-604.
31. Ray C.A., Pickup D.J. The mode of death of pig kidney cells infected with cowpox virus is governed by the expression of the crmA gene. Virology. 217:1996;384-391.
32. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., Irving J.A., Lomas D.A., Luke C.J., Moyer R.W., Pemberton P.A., Remold-O'Donnell E., Salvesen G.S., Travis J., Whisstock J.C. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276:2001;33293-33296.
33. Simonovic M., Gettins P.G.W., Volz K. Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition. Protein Sci. 9:2000;1423-1427.
34. Smith G.L., Vanderplasschen A. Extracellular enveloped vaccinia virus. Entry, egress, and evasion. Adv. Exp. Med. Biol. 440:1998;395-414.
35. Sodeik B., Cudmore S., Ericsson M., Esteban M., Niles E.G., Griffiths G. Assembly of vaccinia virus incorporation of p14 and p32 into the membrane of the intracellular mature virus . J. Virol. 69:1995;3560-3574.
36. Turner P.C., Baquero M.T., Yuan S., Thoennes S.R., Moyer R.W. The Cowpox Virus Serpin SPI-3 Complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin. Virology. 272:2000;267-280.
37. Turner P.C., Moyer R.W. An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse. J. Virol. 66:1992;2076-2085.
38. Turner P.C., Moyer R.W. Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion. J. Virol. 69:1995;5978-5987.
39. Upton C., Macen J.L., Wishart D.S., McFadden G. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology. 179:1990;618-631.
40. van Eijl H., Hollinshead M., Smith G.L. The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology. 271:2000;26-36.
41. Wang Y.X., Turner P.C., Ness T.L., Moon K.B., Schoeb T.R., Moyer R.W. The cowpox virus SPI-3 and myxoma virus SERP1 serpins are not functionally interchangeable despite their similar proteinase inhibition profiles. in vitro. Virology. 272:2000;281-292.
42. Whisstock J.C., Pike R.N., Jin L., Skinner R., Pei X.Y., Carrell R.W., Lesk A.M. Conformational changes in serpins II. The mechanism of activation of antithrombin by heparin . Journal of Molecular Biology. 301:2000;1287-1305.
43. Wilczynska M., Fa M., Karolin J., Ohlsson P.I., Johansson L.B.A., Ny T. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nature Struct. Biology. 4:1997;354-357.
44. Zhou J., Sun X.Y., Fernando G.J., Frazer I.H. The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. Virology. 189:1992;678-686.
45. Zhou Q., Snipas S., Orth K., Muzio M., Dixit V.M., Salvesen G.S. Target protease specificity of the viral serpin CrmA - Analysis of five caspases. J. Biol. Chem. 272:1997;7797-7800.